,16 Independent of T-ALL subgroups, more than 55% of T-ALL cases have recurrent gain-of-function mutations in NOTCH117,18 in the background of expressed RUNX1.10 The gene discussed is RUNX1; the disease is acute lymphoblastic leukemia.